Crossmark

CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma

Crossref DOI link: https://doi.org/10.1038/s41409-019-0528-y

Published Online: 2019-04-23

Published Print: 2020-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jaimovich, Gregorio

Ostriz, Maria Belen Rosales

Castro, Martin

Riera, Leandro

Foncuberta, Cecilia

Longoni, Hector

Cia, Agustina

Duarte, Patricio

Vitriu, Adriana

Lastiri, Francisco

Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
License Information

Text and Data Mining valid from 2019-04-23
More Information

Article History

Received: 21 January 2019

Revised: 26 February 2019

Accepted: 13 March 2019

First Online: 23 April 2019

Compliance with ethical standards

:

: The authors had full access to the data and freedom in the decision to publish. RPG is apart-time employee of Celgene Corp.